Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The concept of essential medicines: lessons for rich countries.

× No keyword cloud information.

8 in total

1. Ten recommendations to improve use of medicines in developing countries.

Authors: R Laing; H Hogerzeil; D Ross-Degnan
Journal: Health Policy Plan Date: 2001-03 Impact factor: 3.344

2. An integrated national pharmaceutical policy for the United Kingdom?

Authors: T Walley; A Earl-Slater; A Haycox; A Bagust
Journal: BMJ Date: 2000-12-16

Review 3. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.

Authors: S H Woolf; R Grol; A Hutchinson; M Eccles; J Grimshaw
Journal: BMJ Date: 1999-02-20

4. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).

Authors:
Journal: World Health Organ Tech Rep Ser Date: 2003

5. Managing the pharmacy benefit in Medicare HMOs: what do we really know?

Authors: H L Lipton; D J Gross; M R Stebbins; L H Syed
Journal: Health Aff (Millwood) Date: 2000 Mar-Apr Impact factor: 6.301

6. Basing prescription drug payment on economic analysis: the case of Australia.

Authors: M F Drummond
Journal: Health Aff (Millwood) Date: 1992 Impact factor: 6.301

7. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Authors: J M Grimshaw; I T Russell
Journal: Lancet Date: 1993-11-27 Impact factor: 79.321

8. A national survey of the arrangements managed-care plans make with physicians.

Authors: M R Gold; R Hurley; T Lake; T Ensor; R Berenson
Journal: N Engl J Med Date: 1995-12-21 Impact factor: 91.245

8 in total

49 in total

1. When did medicines become essential?

Authors: Jeremy A Greene
Journal: Bull World Health Organ Date: 2010-07-01 Impact factor: 9.408

2. Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

Authors: Michel C F Shamy; Clement Zai; Vincenzo S Basile; James L Kennedy; Daniel J Müller; Mario Masellis
Journal: Curr Pharmacogenomics Person Med Date: 2011-06-01

3. The pros and cons of essential medicines for rich countries.

Authors: Marcus M Reidenberg; Tom Walley
Journal: BMJ Date: 2004-11-13

4. Learning from low income countries: poor patients deserve more science and less advocacy.

Authors: Carol C Adelman; Jeremiah Norris
Journal: BMJ Date: 2005-02-26

Review 5. The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries.

Authors: Andrew Lofts Gray; Fatima Suleman
Journal: Int J Clin Pharm Date: 2015-07-17

6. Applying the essential medicines concept to US preferred drug lists.

Authors: Timothy P Millar; Shirley Wong; Donna H Odierna; Lisa A Bero
Journal: Am J Public Health Date: 2011-06-16 Impact factor: 9.308

7. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.

Authors: Steven G Morgan; Winny Li; Brandon Yau; Nav Persaud
Journal: CMAJ Date: 2017-02-27 Impact factor: 8.262

8. Delivering better medicines to children: need for better integration between the science, the policy, and the practice.

Authors: Madlen Gazarian
Journal: Paediatr Drugs Date: 2009 Impact factor: 3.022

9. Returns to Treatment in the Formal Health Care Sector: Evidence from Tanzania.

Authors: Achyuta Adhvaryu; Anant Nyshadham
Journal: Am Econ J Econ Policy Date: 2015-08

10. Essential medicines concept for quality assurance of health care facilities.

Authors: Dixon Thomas; G Seetharam; Gerardo Alvarez-Uria
Journal: J Pharm Bioallied Sci Date: 2012-04